Trial Details

Not Recruiting
Basic Information
Clinical ID c5492
Identifier ACTRN12615000614594
Trial Title A Phase 1, Single-Center, Open-label Study to Evaluate the Pharmacokinetics of PRN1008 in Healthy Male and Female Volunteers
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Rheumatoid Arthritis;Inflammatory Bowel Disease;Systemic Lupus Erythematosus; Rheumatoid Arthritis Inflammatory Bowel Disease Systemic Lupus Erythematosus;Inflammatory and Immune System - Autoimmune diseases
Interventions This will be a single-center, two-period, open-label study to investigate the single dose pharmacokinetics of PRN1008 when administered as a liquid formulation (at 300mg) compared to a capsule formulation under fasted conditions (also at a dosage of 300mg
Participant Information
Sponsor Clinical Network Services (CNS) Pty Ltd
City NULL
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type Interventional
Phase PHASE1
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL